SCHEMBL637111

SCHEMBL637111

O=[N+]([O-])C(C(O)Br)C(C(O)Br)[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
HIF1A Q16665 1/20 0.50
CA5A P35218 1/20 0.33
CA5B Q9Y2D0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4008463 0.75
SCHEMBL459446 0.71
SCHEMBL10484240 0.69 ALDH1A1 (0.35) ALDH1A1HPGDHIF1ACA5ACA5B
SCHEMBL3594959 0.68
SCHEMBL1778868 0.68
SCHEMBL767030 0.67
SCHEMBL9285137 0.67 ALDH1A1 (0.47) ALDH1A1HPGDHIF1ACA5ACA5B
SCHEMBL10454609 0.67
SCHEMBL10454706 0.65
SCHEMBL92211 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163029-B1 NITRATE ESTERS AND THEIR USE FOR INDUCING NEUROPROTECTION AND COGNITION ENHANCEMENT UNIV KINGSTON (CA) 2012-02-22 EP disclosed
EP-1797100-A4 NITRATE ESTERS AND THEIR USE FOR MITIGATING CELLULAR DAMAGE UNIV KINGSTON (CA) 2009-05-13 EP disclosed
EP-1797100-A1 NITRATE ESTERS AND THEIR USE FOR MITIGATING CELLULAR DAMAGE QUEEN'S UNIVERSITY AT KINGSTON (CA) 2007-06-20 EP disclosed
US-20070066575-A1 Methods and compositions for mitigating pain QUEEN'S UNIVERSITY AT KINGSTON (CA) 2007-03-22 US disclosed
US-7115661-B1 Methods and compositions for mitigating pain QUEEN'S UNIVERSITY AT KINGSTON (CA) 2006-10-03 US disclosed
WO-2006029532-A1 NITRATE ESTERS AND THEIR USE FOR MITIGATING CELLULAR DAMAGE QUEEN'S UNIVERSITY AT KINGSTON (CA) 2006-03-23 WO disclosed
US-6916835-B2 Nitrate esters and their use for neurological conditions QUEEN'S UNINVERSITY AT KINGSTON (CA) 2005-07-12 US disclosed
US-20050137191-A1 Nitrate esters and their use for mitigating cellular damage QUEEN'S UNIVERSITY AT KINGSTON (CA) 2005-06-23 US disclosed
EP-1518553-A2 Use of nitrate ester compounds for treating pain or providing analgesia QUEEN'S UNIVERSITY AT KINGSTON (CA) 2005-03-30 EP disclosed
EP-1246625-B1 USES AND COMPOSITIONS OF NITRATE ESTERS FOR PROVIDING SEDATION UNIV KINGSTON (CA) 2004-12-01 EP disclosed
US-6677374-B2 NERVOUS SYSTEM DISORDERS QUEEN'S UNIVERSITY AT KINGSTON (CA) 2004-01-13 US disclosed
US-20020177622-A1 Nitrate esters and their use for neurological conditions QUEEN'S UNIVERSITY AT KINGSTON (CA) 2002-11-28 US disclosed
US-20020147234-A1 Nitrate esters and methods of making same QUEEN'S UNIVERSITY AT KINGSTON (CA) 2002-10-10 US disclosed
EP-1246625-A2 METHODS AND COMPOSITIONS FOR MITIGATING PAIN USING NITRATE ESTERS QUEEN'S UNIVERSITY AT KINGSTON (CA) 2002-10-09 EP disclosed
US-6365579-B2 MITIGATING NEURODEGENERATION, EFFECTING NEUROPROTECTION AND/OR EFFECTING COGNITION ENHANCEMENT QUEEN'S UNIVERSITY AT KINGSTON (CA) 2002-04-02 US disclosed
US-20020016311-A1 Nitrate esters and their use for neurological conditions QUEEN'S UNIVERSITY AT KINGSTON (CA) 2002-02-07 US disclosed
EP-1163029-A2 NITRATE ESTERS AND THEIR USE FOR INDUCING NEUROPROTECTION AND COGNITION ENHANCEMENT QUEEN'S UNIVERSITY AT KINGSTON (CA) 2001-12-19 EP disclosed
US-6310052-B1 TREATING ISCHEMIA BY ADMINISTERING A NITRATE ESTER OF GIVEN FORMULA QUEEN'S UNIVERSITY AT KINGSTON (CA) 2001-10-30 US disclosed
WO-2001049275-A2 METHODS AND COMPOSITIONS FOR MITIGATING PAIN USING NITRATE ESTERS QUEEN'S UNIVERSITY AT KINGSTON (CA) 2001-07-12 WO disclosed
WO-2000054756-A2 NITRATE ESTERS AND THEIR USE FOR INTRODUCING NEUROPROTECTION AND COGNITION ENHANCEMENT QUEEN'S UNIVERSITY AT KINGSTON (CA) 2000-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016311-A1 Nitrate esters and their use for neurological conditions NLN, NOS1, NOS2 ALDH1A1 1596/4885HPGD 412/4885HIF1A 1405/4885
US-20070066575-A1 Methods and compositions for mitigating pain NOS2, OPRK1, NOS3 ALDH1A1 662/4885HPGD 216/4885HIF1A 130/4885
US-20020177622-A1 Nitrate esters and their use for neurological conditions NLN, NOS1, NOS2 ALDH1A1 1596/4885HPGD 412/4885HIF1A 1405/4885
US-20050137191-A1 Nitrate esters and their use for mitigating cellular damage NLN, NOS1, NOS3 ALDH1A1 1555/4885HPGD 275/4885HIF1A 850/4885
US-20020147234-A1 Nitrate esters and methods of making same NOS1, NLN, NOS2 ALDH1A1 1245/4885HPGD 229/4885HIF1A 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.